ReleaseWire Connect

Green tea was developed in China as a classic traditional medicine derived from leaves of camellia Sinensis. Green tea leaves doesn't undergo withering and oxidation process by which it is used to make oolong teas and black teas. Green tea have several health benefits such as lower risk of cardio vascular diseases, hyperlipidimea, high blood sugar levels and others.

According to a new market research report "Probiotic dietary supplements Market By Type (Sports Supplements, Food Supplements, Infant Formula, Nutrition Supplements And Specialty Nutrients) - Global Forecast to 2022", published by MarketDataForecast™, the market is expected to reach USD 5.09 Billion by 2022 from USD 3.54 Billion in 2016, at a CAGR of 7.9%. Factors driving the growth of this market include Excessive use of antibiotics in everyday life has resulted in the increase in demand for probiotic supplements. Increasing digestive disorders in infants and adults, high emphasis on research and technological advancements has aided the Probiotic dietary supplements market.

The report on "Liquid Biopsy Market by Cancer Type (Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers) by Sample Type (Blood, Urine, Plasma, Saliva and Cerebrospinal) by Diagnostic Approach (Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles), By End Users (Reference Laboratories, Hospital/Physician Laboratories, Academic and Research Centers, and Other End Users) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", is published by Market Data Forecast. The Global Liquid Biopsy Market was priced USD 590.2 million in 2016 and calculable to be growing at a CAGR of 24.3 %, to achieve USD 1.75 billion by 2021, in the forecast period from 2016 to 2021. The liquid biopsy technology consists of diagnostic and treatment procedures for medicine and it's believed to rework the clinical practice. A Liquid biopsy is used for diagnostic purposes, such as treatment monitoring in a blood test, expression profiling, and tumour diagnosis and response estimation. A liquid biopsy might capture the whole heterogeneity of the illness. This technique is advantageous for monitoring of a tumour genomic which is done by taking serial samples.

According to a new market research report "Enteral Feeding Formulas Market, by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Paediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care)-Forecast 2022", rising frequencies of unending illnesses and scatters, quickly developing geriatric populace, expanding social insurance consumption, rising commonness of preterm births, and expanding interest for homecare are the propelling the market growth at a CAGR of 7.87%. In 2017, the global market was estimated to be USD 4.01 Billion and is expected to be about USD 5.86 Billion by 2022.

According to a new market research report " Pregnancy Testing Market By Product Type (Pregnancy Test Kits, Ovulation/Fertility Test Kits) By Test Type (FSH Urine Test, Luteinizing Hormone (LH) Urine Test, Human Chorionic Gonadotropin (HCG) Hormone Blood Test, Human Chorionic Gonadotropin (HCG) Hormone Urine Test) - Global Forecast to 2022", published by MarketDataForecast™, the market is expected to reach USD 1564.7 Million by 2022 from USD 1165.2 Million in 2016, at a CAGR of 5.1%. Factors driving the growth of this market are Mounting first-time pregnancy age, technological advancements and key product features.

Generic drugs are copies of branded drugs that have same composition, effects, risks, and functions as the original drug but at a lower price and usually subject to government regulations in the countries where they are dispensed. Generic drugs are also known as abbreviated drugs. To sell a generic drug manufacturing company must submit an Abbreviated New Drug Application for approval. The Drug Price Competition and Patent Term Restoration Act of 1984, mostly known as the Hatch-Waxman Act, made ANDAs feasible by creating a compromise in the drug industry. Generic drug companies have obtained greater access to the market for prescription drugs, and branded companies have obtained restoration of patent life for their drugs lost during FDA's approval process.

The report "Antacid Market by submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents), Application (Novel dietary fibers), Ingredients (Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes) - Forecast to 2021", The Antacid market is expected to reach USD 5.88 Billion by 2021 from an estimated USD 3.88 Billion in 2016, at a CAGR of 2.5%. The key factors such as better formulation, route of administration growing demand for personalized medicine are driving the growth of this market.

Market Data Forecast has announced the addition of the "Laboratory Information System Market by component (Services, hardware and Software) by end-users (hospitals, independent laboratories, clinics and others) by delivery mode (cloud based and on-premises) and by region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" report to their offering. The Global Laboratory Information System Market was priced USD $1.24 Billion market in 2016 and calculable to be growing at a CAGR of 8.8%, to achieve USD $1.89 Billion by 2021, within the mentioned forecast period.

The report "Glucose Monitoring Device Market by Device Type (Continuous Wearable Devices (Sensors, Transmitters and Activators) and Self-Monitoring Devices (Blood Glucose Meters, Blood Glucose Strips, Lancets, and Haemoglobin A1C testing Kits)) by Application (Hospitals, Clinics and Diagnostic Centres, Home Setting and Ambulatory Settings), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)", The glucose monitoring device market is projected to reach $2.30 Billion by 2021, from the valuation of $6.24 Billion in 2016. Increasing awareness about diabetes across all over the world is the key driver behind the market growth.

The report on " Feed Enzymes market by type of ingredient (Carbohydrase, Phytase, others), by type of animals (Ruminant, Swine, Poultry, Aquaculture and other), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" is published by Market Data Forecast. The Global Feed Enzymes market was priced USD 85.5 Billion in 2016 and calculable to be growing at a CAGR of 6.7%, to achieve USD 118.25 Billion by 2021, within the mentioned forecast period from 2016 to 2021.